Attached files
| file | filename |
|---|---|
| S-1MEF - S-1MEF - PLx Pharma Inc. | a14-8042_1s1mef.htm |
| EX-5.1 - EX-5.1 - PLx Pharma Inc. | a14-8042_1ex5d1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of Dipexium Pharmaceutical LLC (now known as Dipexium Pharmaceuticals, Inc.) of our report, which includes an explanatory paragraph related to Dipexium Pharmaceutical LLC’s ability to continue as a going concern, dated February 5, 2014, on our audits of the financial statements of Dipexium Pharmaceutical LLC as of December 31, 2013 and 2012 and for each of the years in the two year period ended December 31, 2013 and the period from January 14, 2010 (date of inception) through December 31, 2013, and included in the Registration Statement Form S-1 No. 333-193780 (as amended). We also consent to the reference to our firm under the caption “Experts”.
/S/ CohnReznick LLP
Roseland, New Jersey
March 12, 2014